Replies to post #98950 on Anavex Life Sciences Corp (AVXL)

[neiu]

I don't think xena meant skip 15 but instead to wait for 18 and present both at the same time. This is what happened at CTAD when they waited for 9 and 12 month data to be presented together. People again complained that they didn't give them the 9 month data when the time had passed and yet the share price has only risen from that. If you want to make a bet on good or bad news in biotech then you have only yourself to blame if you don't win. Trust me I've been burned many times making that bet, or even thinking that a company would receive a CRL instead of approval and selling out too early. I think people forget that this is not big BP but micro-cap bio trying extremely hard to have their science validated however way they can in a field that has seen billions of dollars go down the drain with the most failures in drug development. Get real if you think that this is going to move like clockwork, there is much patience and work to be done to make sure they get to the finish line without failing out or going bankrupt first.